Priority Date: 24.07.12 (US 201261675276P)

A NOVEL METHOD TO DETECT RESISTANCE TO CHEMOTHERAPY IN PATIENTS WITH LUNG CANCER

  • Application ID: EP13822940
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1995
1165.89
Headquarter in Leeds and 13 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 173 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 24.07.2012 - Priority Date (US 201261675276P)
  • 30.01.2014 - Publication A2 (WO2014018683)
  • 03.06.2015 - Publication A2 (EP2877210)